The NHS Health Check in England: an evaluation of the first 4 years
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Objectives: To describe implementation of a new national preventive programme to reduce cardiovascular morbidity. Design: Observational study over 4 years (April 2009—March 2013). Setting: 655 general practices across England from the QResearch database. Participants: Eligible adults aged 40–74 years including attendees at a National Health Service (NHS) Health Check. Intervention: NHS Health Check: routine structured cardiovascular check with support for behavioural change and in those at highest risk, treatment of risk factors and newly identified comorbidity. Results: Of 1.68 million people eligible for an NHS Health Check, 214 295 attended in the period 2009–12. Attendance quadrupled as the programme progressed; 5.8% in 2010 to 30.1% in 2012. Attendance was relatively higher among older people, of whom 19.6% of those eligible at age 60–74 years attended and 9.0% at age 40–59 years. Attendance by population groups at higher cardiovascular disease (CVD) risk, such as the more socially disadvantaged 14.9%, was higher than that of the more affluent 12.3%. Among attendees 7844 new cases of hypertension (38/1000 Checks), 1934 new cases of type 2 diabetes (9/1000 Checks) and 807 new cases of chronic kidney disease (4/1000 Checks) were identified. Of the 27 624 people found to be at high CVD risk (20% or more 10-year risk) when attending an NHS Health Check, 19.3% (5325) were newly prescribed statins and 8.8% (2438) were newly prescribed antihypertensive therapy. Conclusions: NHS Health Check coverage was lower than expected but showed year-on-year improvement. Newly identified comorbidities were an important feature of the NHS Health Checks. Statin treatment at national scale for 1 in 5 attendees at highest CVD risk is likely to have contributed to important reductions in their CVD events.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, uptake has been lower than expected,26 and research on their utility is inconclusive.27,28”
From Dementia prevention and the GP’s role: a qualitative interview study (2024) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040296 · Cited by 23,020
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.11.008 · Cited by 17,893
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00010 · Cited by 17,796
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
SCANDINAVIANSIMVASTATINSURVIVAL (1994) · The Lancet · doi:10.1016/s0140-6736(94)90566-5 · Cited by 3,645
Collaborators, C. T. T. (. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60367-5 · Cited by 2,833 · cited 1×
“8% (10 560) were treated with antihypertensives; if each treatment reduces cardiovascular risk by 20%, it is estimated that 2529 people would avoid a major CVD event over a 5-year period.(11) 12 Higher uptake in recent years and additional treatment in people at both high CVD risk and at lower CVD risk make this a con…”
Statins for the primary prevention of cardiovascular disease
Taylor, F., Huffman, M. D., Macedo, A. F., Moore, T. H., Burke, M., Davey Smith, G., Ward, K., Ebrahim, S., & Gay, H. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004816.pub5 · Cited by 1,934
Tuomilehto, J., Vidgren, G., Toivanen, L., Tuomilehto-Wolf, E., Kohtamaki, K., Stengård, J., Zimmet, P., Mackay, I. R., Rowley, M., & Koskela, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92521-6 · Cited by 1,692
Health and Deprivation: Inequality and the North
Townsend, P. D., Phillimore, P., & Beattie, A. (1987) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 1,473
Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2
Hippisley-Cox, J., Coupland, C., Vinogradova, Y., Robson, J., Minhas, R., Sheikh, A., & Brindle, P. (2008) · BMJ · doi:10.1136/bmj.39609.449676.25 · Cited by 1,459
Self-citationRobson, J. (2008) · Heart · doi:10.1136/hrt.2008.150979 · Cited by 551
Self-citationMultiple risk factor interventions for primary prevention of coronary heart disease
Ebrahim, S., Taylor, F., Ward, K., Beswick, A., Burke, M., & Davey Smith, G. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001561.pub3 · Cited by 546
Jørgensen, T., Borch-Johnsen, K., Thomsen, T. F., Ibsen, H., Glümer, C., & Pisinger, C. (2003) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000096541.30533.82 · Cited by 417
Krogsboll, L. T., Jorgensen, K. J., Gronhoj Larsen, C., & Gotzsche, P. C. (2012) · BMJ · doi:10.1136/bmj.e7191 · Cited by 327
The multifactor primary prevention trial in Göteborg, Sweden
WILHELMSEN, L., BERGLUND, G., ELMFELDT, D., TIBBLIN, G., WEDEL, H., PENNERT, K., VEDIN, A., WILHELMSSON, C., & WERKÖ, L. (1986) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a062065 · Cited by 313
Jorgensen, T., Jacobsen, R. K., Toft, U., Aadahl, M., Glumer, C., & Pisinger, C. (2014) · BMJ · doi:10.1136/bmj.g3617 · Cited by 296
Screening for cardiovascular risk in asymptomatic patients
Berger, J. S., Jordan, C. O., Lloyd-Jones, D., & Blumenthal, R. S. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.09.066 · Cited by 238
Czernichow, S., Zanchetti, A., Turnbull, F., Barzi, F., Ninomiya, T., Kengne, A.-P., Lambers Heerspink, H. J., Perkovic, V., Huxley, R., Arima, H., et al. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834000be · Cited by 207
Ioannidis, J. P. A. (2014) · JAMA · doi:10.1001/jama.2013.284657 · Cited by 188
Multiphasic Health Checkup Evaluation: A 16-year follow-up
Friedman, G. D., Collen, M. F., & Fireman, B. H. (1986) · Journal of Chronic Diseases · doi:10.1016/0021-9681(86)90112-8 · Cited by 187
Holland, W. W., Creese, A., D'Souza, M. F., Partridge, J. R. J., Shannon, D., Stone, D. H., Swan, A. V., Trevelyan, H., Tuckman, E., & Woodall, H. J. T. (1977) · International Journal of Epidemiology · doi:10.1093/ije/6.4.357 · Cited by 131
Wells, S., Furness, S., Rafter, N., Horn, E., Whittaker, R., Stewart, A., Moodabe, K., Roseman, P., Selak, V., Bramley, D., et al. (2008) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e3282f13af4 · Cited by 109 · cited 1×
“28 This algorithm is fully integrated with the electronic primary care record, a key enabling factor for implementation.(29)”
Prochazka, A. V., Lundahl, K., Pearson, W., Oboler, S. K., & Anderson, R. J. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.12.1347 · Cited by 105
A Controlled Trial of Multiphasic Screening
Olsen, D. M., Kane, R. L., & Proctor, P. H. (1976) · New England Journal of Medicine · doi:10.1056/nejm197604222941705 · Cited by 100
Hill, S., Spink, J. D., Cadilhac, D. A.-M., Edwards, A., Kaufman, C., Rogers, S., Ryan, R. E., & Tonkin, A. (2010) · BMC Public Health · doi:10.1186/1471-2458-10-108 · Cited by 79
Özdal, M. A., Dalton, A. R., Majeed, A., Car, J., & Millett, C. J. (2013) · Preventive Medicine · doi:10.1016/j.ypmed.2013.05.002 · Cited by 67
The efficiency of cardiovascular risk assessment: do the right patients get statin treatment?
van Staa, T. P., Smeeth, L. L., Ng, E. S. W., Goldacre, B. M., & Gulliford, M. C. (2013) · Heart · doi:10.1136/heartjnl-2013-303698 · Cited by 62 · cited 2×
“5 There is limited evidence of effectiveness(35) or comorbidities identified(36) and statin uptake in those at high risk was reported to be between 20% and 50%,(5) 25 which accords with national surveys of 32%.(37) Despite a statin treatment rate of only 19% in high-risk attendees in this study, this is likely to have…”
Will screening individuals at high risk of cardiovascular events deliver large benefits? No
Capewell, S. (2008) · BMJ · doi:10.1136/bmj.a1395 · Cited by 56
Drug-induced valvular heart disease
Cosyns, B., Droogmans, S., Rosenhek, R., & Lancellotti, P. (2012) · Heart · doi:10.1136/heartjnl-2012-302239 · Cited by 54
The NHS Health Check programme: implementation in east London 2009–2011
Robson, J. P., Dostal, I., Madurasinghe, V., Sheikh, A., Hull, S., Boomla, K., Page, H., Griffiths, C. J., & Eldridge, S. M. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-007578 · Cited by 48
Self-citationTheobald, H. (1998) · International Journal of Epidemiology · doi:10.1093/ije/27.2.194 · Cited by 43
Variations in the organization and delivery of the 'NHS health check' in primary care
Nicholas, J. M., Burgess, C. C., Dodhia, H., Miller, J. M., Fuller, F., Cajeat, E., & Gulliford, M. C. (2012) · Journal of Public Health · doi:10.1093/pubmed/fds062 · Cited by 40
Artac, M., Dalton, A. R. H., Babu, H., Bates, S., Millett, C., & Majeed, A. (2013) · Journal of Public Health · doi:10.1093/pubmed/fdt069 · Cited by 40 · cited 1×
“35 Nationally, uptake in 2011–2012 was reported as 45%, with high levels of variability and better uptake in more deprived areas.(6) 5 There is limited evidence of effectiveness(35) or comorbidities identified(36) and statin uptake in those at high risk was reported to be between 20% and 50%,(5) 25 which accords with…”
Optimal Cardiovascular Prevention Strategies for the 21st Century
Capewell, S., & Lloyd‐Jones, D. M. (2010) · JAMA · doi:10.1001/jama.2010.1641 · Cited by 37 · cited 1×
“For people at lower CVD risk (ie, a 10-year risk of <10%) for whom behavioural change is the main intervention, the most effective prevention strategy remains unclear.(16) Primary prevention based on assessment of cardiovascular risk is a topic of international interest and debate.”
Liew, S. M., Blacklock, C., Hislop, J., Glasziou, P., & Mant, D. (2013) · British Journal of General Practice · doi:10.3399/bjgp13x668195 · Cited by 34
Krska, J., du Plessis, R., & Chellaswamy, H. (2014) · Journal of Public Health · doi:10.1093/pubmed/fdu054 · Cited by 30
Universal health checks should be abandoned
Krogsboll, L. T., Jørgensen, K. J., & Gøtzsche, P. C. (2013) · BMJ · doi:10.1136/bmj.f5227 · Cited by 28
Mehta, S., Wells, S., Grey, C., Riddell, T., Kerr, A., Marshall, R., Ameratunga, S. N., Harrison, J., Kenealy, T. W., Bramley, D. M., et al. (2012) · European Journal of Preventive Cardiology · doi:10.1177/2047487312462150 · Cited by 28
Will screening individuals at high risk of cardiovascular events deliver large benefits? Yes
Jackson, R., Wells, S., & Rodgers, A. J. (2008) · BMJ · doi:10.1136/bmj.a1371 · Cited by 27
Tibblin, G., Welin, L., Larsson, B., Ljungberg, I.-L., & Svärdsudd, K. (1982) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488201000106 · Cited by 26
Thomsen, J. L., Parner, E. T., Karlsmose, B., Thulstrup, A. M., Lauritzen, T., & Engberg, M. (2005) · Family Practice · doi:10.1093/fampra/cmi007 · Cited by 21
Effects of a Health Screening on Mortality and Causes of Death in Middle-Aged Men
Lannerstad, O., Sternby, N. H., Isacsson, S., Lindgren, G., & Lindell, S. (1977) · Scandinavian Journal of Social Medicine · doi:10.1177/140349487700500305 · Cited by 21
Godlee, F. (2014) · BMJ · doi:10.1136/bmj.g5038 · Cited by 19
Is general practice in trouble?
Appleby, J. (2014) · BMJ · doi:10.1136/bmj.g6814 · Cited by 18
Smith, S. A., Waterall, J., & Burden, A. C. (2013) · BMJ Open · doi:10.1136/bmjopen-2012-002219 · Cited by 16
Primary care in England: coping with financial austerity
Majeed, A., Rawaf, S., & Maeseneer, J. D. (2012) · British Journal of General Practice · doi:10.3399/bjgp12x659150 · Cited by 15
Shapiro, S., Fink, R., & Rosenberg, C. (1972) · Medical Care · doi:10.1097/00005650-197205000-00003 · Cited by 13
A study to evaluate the effectiveness of multiphasic screening in Yugoslavia
Thorner, R. M., Djordjevic, D., Vuckmanovic, C., Pesic, B., Culafic, B., & MARK, F. D. (1973) · Preventive Medicine · doi:10.1016/0091-7435(73)90072-8 · Cited by 12
Sheikh, A., Nurmatov, U. B., Cresswell, K. M., & Bates, D. W. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-003737 · Cited by 9 · cited 1×
“QRisk2 was used in 80% of NHS Checks reported in this study and is fully integrated with the EMIS computer systems used by general practitioners in this study and has since been recommended as the risk algorithm of choice in the 2014 NICE guidance;(26) an example of successful translation of clinical decision support…”
Self-citationImpact of a Screening Programme in General Practice: A Randomized Controlled Trial
BENNETT, A. E., & FRASER, I. G. P. (1972) · International Journal of Epidemiology · doi:10.1093/ije/1.1.55 · Cited by 9
Cited by
Hippisley-Cox, J., Coupland, C., & Brindle, P. (2017) · BMJ · doi:10.1136/bmj.j2099 · Cited by 1,703
Self-citationZhou, B., Danaei, G., Stevens, G. A., Bixby, H., Taddei, C., Carrillo-Larco, R. M., Solomon, B., Riley, L. M., Di Cesare, M., Iurilli, M. L. C., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31145-6 · Cited by 544
Plasma protein patterns as comprehensive indicators of health
Williams, S. A., Kivimaki, M., Langenberg, C., Hingorani, A. D., Casas, J. P., Bouchard, C., Jonasson, C., Sarzynski, M. A., Shipley, M. J., Alexander, L., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0665-2 · Cited by 506
Insights into Systemic Disease through Retinal Imaging-Based Oculomics
Wagner, S. K., Fu, D. J., Faes, L., Liu, X., Huemer, J., Khalid, H., Ferraz, D., Korot, E., Kelly, C., Balaskas, K., et al. (2020) · Translational Vision Science & Technology · doi:10.1167/tvst.9.2.6 · Cited by 305
Kuan, V., Denaxas, S., Gonzalez-Izquierdo, A., Direk, K., Bhatti, O., Husain, S., Sutaria, S., Hingorani, M., Nitsch, D., Parisinos, C. A., et al. (2019) · The Lancet Digital Health · doi:10.1016/s2589-7500(19)30012-3 · Cited by 305
Metadata
- Authors
- Robson, J., Dostal, I., Sheikh, A., Eldridge, S., Madurasinghe, V., Griffiths, C., Coupland, C., & Hippisley-Cox, J.
- Affiliations
- Queen Mary University of London (GB)
- University of Edinburgh (GB)
- University of Nottingham (GB)
- School of Community Health Sciences, The University of Nottingham, Nottingham, UK
- Corresponding author
- Robson, John
- ORCID
- Venue
- BMJ Open
- Publisher
- BMJ
- Published
- 2016-01
- Volume
- 6
- Issue
- 1
- Pages
- e008840
- ISSN
- 2044-6055 (ISSN-L)
- PMC
- PMC4735215
- OpenAlex
- W2236077962
- Cited by
- 184
- References
- 54
- Citations by year
- 2026: 11 · 2025: 11 · 2024: 9 · 2023: 17 · 2022: 20 · 2021: 16 · 2020: 19 · 2019: 26 · 2018: 26 · 2017: 24 · 2016: 5
- FWCI
- 26.62
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- BMJ Open (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (publishedVersion, cc-by)
- Repository@Nottingham (University of Nottingham) (submittedVersion, cc-by)
- Nottingham ePrints (University of Nottingham) (submittedVersion, cc-by)
- Repository@Nottingham (University of Nottingham) (submittedVersion, other-oa)
- HighWire Press Open Archive (submittedVersion)
- Queen Mary Research Online (Queen Mary University of London) (submittedVersion, cc-by)
- Funders
- Commonwealth Fund
- National Institute for Health and Care Research
- University of Nottingham
- Medical Research Council (MR/K006584/1)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Health Sciences › Medicine › Epidemiology › Healthcare Systems and Public Health
- Keywords
- NHS Health Check, cardiovascular disease prevention, preventive health screening, program implementation, screening uptake, hypertension detection, chronic kidney disease, statin prescribing, antihypertensive therapy, cardiovascular risk, comorbidities, general practice, social deprivation
- MeSH terms
- Adult, Aged, Cardiovascular Diseases, England, Female, Health Promotion, Humans, Male, Middle Aged, Socioeconomic Factors, State Medicine, Age Distribution, Sex Distribution, Risk Assessment, Early Diagnosis, General Practice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
